Tiziana Life Sciences Ltd
TLSA
$0.81
$0.00991.24%
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.13M | 1.13M | 1.18M | 1.18M | 6.60M |
Total Receivables | 6.27M | 6.27M | 5.93M | 5.93M | 7.89M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 355.00K | 355.00K | 102.00K | 102.00K | 691.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 121.00K | 121.00K | -- |
Total Current Assets | 7.75M | 7.75M | 7.34M | 7.34M | 15.18M |
|
|||||
Total Current Assets | 7.75M | 7.75M | 7.34M | 7.34M | 15.18M |
Net Property, Plant & Equipment | 245.00K | 245.00K | 293.00K | 293.00K | 351.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 10.96M | 10.96M | 12.18M | 12.18M | 17.42M |
|
|||||
Total Accounts Payable | 7.48M | 7.48M | 4.14M | 4.14M | 2.95M |
Total Accrued Expenses | 1.44M | 1.44M | 2.25M | 2.25M | 816.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 142.00K | 142.00K | 138.00K | 138.00K | 170.00K |
Total Finance Division Other Current Liabilities | 8.00K | 8.00K | 14.00K | 14.00K | 6.00K |
Total Other Current Liabilities | 8.00K | 8.00K | 14.00K | 14.00K | 6.00K |
Total Current Liabilities | 9.07M | 9.07M | 6.54M | 6.54M | 3.94M |
|
|||||
Total Current Liabilities | 9.07M | 9.07M | 6.54M | 6.54M | 3.94M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 37.00K | 37.00K | 109.00K | 109.00K | 183.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 9.11M | 9.11M | 6.65M | 6.65M | 4.12M |
|
|||||
Common Stock & APIC | 17.02M | 17.02M | 16.60M | 16.60M | 15.70M |
Retained Earnings | -138.27M | -138.27M | -133.68M | -133.68M | -124.88M |
Treasury Stock & Other | 123.11M | 123.11M | 122.62M | 122.62M | 122.48M |
Total Common Equity | 1.86M | 1.86M | 5.54M | 5.54M | 13.30M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.86M | 1.86M | 5.54M | 5.54M | 13.30M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.86M | 1.86M | 5.54M | 5.54M | 13.30M |
|